Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson’s disease: a case report
Key Points
Extreme blood pressure lability was observed following the combination of levodopa, benserazide, selegiline, and piribedil.
A 65-year-old male with Parkinson’s experienced significant blood pressure changes when treated with these medications.
Treatment included combined administration of levodopa, benserazide, selegiline, and piribedil, which led to abnormal physiological responses.
Highlights the potential risks associated with polypharmacy in Parkinson’s disease management; further investigation needed.
Catecholaminergic storm and extreme blood pressure lability induced by combined levodopa/benserazide, selegiline, and piribedil in Parkinson’s disease: a case report | Synapse